Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Spontaneous Subarachnoid Hemorrhage

NCT06008795 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06008795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Spontaneous Subarachnoid Hemorrhage
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Recruiting
Start date
December 17, 2023
Completion date
February 28, 2027
Enrollment
195 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

headache, subarachnoid hemorrhage, aneurysmal